Language

News topic

Active ingredient Aciclovir

Current shortage notices for the active ingredient Aciclovir, structured by product, country and reporting period.

6 notices

← All shortages

What the Aciclovir notices indicate for the supply chain

The 6 consolidated notices from Germany, Belgium, Austria are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Aciclovir GSK I.V. 250 mg inj. sol. (pwdr.) i.v. vial 5 x 250 mg

Active ingredient: Aciclovir

View notice details →
Belgium

Aciclovir Hospira 25 mg/ml inf. sol. (conc.) i.v. vial 5 x 20 ml

Active ingredient: Aciclovir

View notice details →
Belgium

Aciclovir Hospira 25 mg/ml inf. opl. (conc.) i.v. flac. 5 x 20 ml

Active ingredient: Aciclovir

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.